Motley Fool  Nov 11  Comment 
A lack of broader Congressional follow-through on prescription drug reform lights a fire under Ariad shares in October.
Mondo Visione  Nov 4  Comment 
Speakerbus, the specialist provider of critical voice solutions to the world’s leading financial institutions, today announced the launch of iManager ARIA.  The launch is the result of an innovation grant which was awarded by the UK...
Benzinga  Sep 15  Comment 
Yahoo! Inc. (NASDAQ: YHOO) shares dipped 3.20 percent to $29.35 in pre-market trading after falling 3.53 percent on Monday. Vodafone Group Plc (ADR) (NASDAQ: VOD) shares fell 2.68 percent to $33.37 in pre-market trading after declining 1.15...
Motley Fool  Sep 7  Comment 
Could a buyout be in the cards for Ariad Pharmaceuticals? According to one report, it's a possibility.
FierceBiotech  Sep 2  Comment 
Last week's buzz that Baxalta, angling to shake off some unwanted buyout attention from Shire, had set sights on Ariad Pharmaceuticals sent the latter company's shares soaring. But negotiations between the two have since fallen apart, according to...


Ariad Pharmaceuticals develops products that use intracellular-signal-transduction pathways to treat disease. It is developing pharmaceuticals that may treat conditions such as anemia, growth-hormone deficiency, cancer, diabetes, asthma, arthritis, and osteoporosis. All of the company's products are in the research or clinical-testing stages. Ariad has not entered any partnerships for the distribution of their product candidates, preferring to have sole control of their development.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki